ROCKVILLE, Md. (AP) _ Synthetic Biologics Inc. (SYN) on Thursday reported a loss of $2.5 million in its fourth quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 2 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
For the year, the company reported that its loss widened to $27.3 million, or 29 cents per share.
In the final minutes of trading on Thursday, the company's shares hit 79 cents. A year ago, they were trading at $1.95.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SYN at https://www.zacks.com/ap/SYN
Keywords: Synthetic Biologics, Earnings Report